Omeros (OMER) Short-term Investments (2010 - 2026)
Omeros' (OMER) quarterly Short-term Investments came in at $133.4 million in Q1 2026, up 177.07% year-on-year from $48.1 million in Q1 2025, and down 17.72% quarter-over-quarter from $162.1 million in Q4 2025.
Omeros (OMER) Short-term Investments (2010 - 2026) Analysis & Trends
Omeros has disclosed Short-term Investments across 17 years of filings, most recently posting $133.4 million for Q1 2026.
- Short-term Investments for Q1 2026 came in at $133.4 million, up 177.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $133.4 million (up 177.07% YoY), and the FY2025 annual result was $162.1 million, up 86.95% from the prior year.
- Short-term Investments came in at $133.4 million for Q1 2026 at Omeros, down from $162.1 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $367.5 million in Q1 2023 to a low of $26.8 million in Q2 2025.
- The 5-year median for Short-term Investments is $133.4 million (2026), against an average of $155.6 million.
- Across the five-year window, Short-term Investments jumped 270.76% in 2023 and sank 82.88% in 2025, its largest moves.
- Omeros' Short-term Investments stood at $183.9 million in 2022, then fell by 10.42% to $164.7 million in 2023, then tumbled by 47.35% to $86.7 million in 2024, then jumped by 86.95% to $162.1 million in 2025, then decreased by 17.72% to $133.4 million in 2026.
- The last three Short-term Investments figures came in at $133.4 million (Q1 2026), $162.1 million (Q4 2025), and $33.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Omeros | 628.56 Mn | 493.24 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 133.41 Mn |
| Dec 31, 2025 | 162.14 Mn |
| Sep 30, 2025 | 33.69 Mn |
| Jun 30, 2025 | 26.84 Mn |
| Mar 31, 2025 | 48.15 Mn |
| Dec 31, 2024 | 86.73 Mn |
| Sep 30, 2024 | 121.64 Mn |
| Jun 30, 2024 | 156.79 Mn |
| Mar 31, 2024 | 228.50 Mn |
| Dec 31, 2023 | 164.74 Mn |
| Sep 30, 2023 | 279.67 Mn |
| Jun 30, 2023 | 334.68 Mn |
| Mar 31, 2023 | 367.53 Mn |
| Dec 31, 2022 | 183.91 Mn |
| Sep 30, 2022 | 75.43 Mn |
| Jun 30, 2022 | 108.43 Mn |
| Mar 31, 2022 | 133.27 Mn |
| Dec 31, 2021 | 56.46 Mn |
| Sep 30, 2021 | 42.96 Mn |
| Jun 30, 2021 | 60.96 Mn |